Sartori, Simone B.

Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders

Sartori, S. B., & Singewald, N. (2019) · Pharmacology & Therapeutics

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeuroscience and Neuropharmacology Research

Cited by 236

Fetal Down Syndrome Brains Exhibit Aberrant Levels of Neurotransmitters Critical for Normal Brain Development

Whittle, N., Sartori, S. B., Dierssen, M., Lubec, G., & Singewald, N. (2007) · Pediatrics

Down syndrome and intellectual disability researchGenetics and Neurodevelopmental Disorders

Cited by 127

Dysregulation of select ATP-dependent chromatin remodeling factors in high trait anxiety

Wille, A., Amort, T., Singewald, N., Sartori, S. B., & Lusser, A. (2016) · Behavioural Brain Research

Genomics and Chromatin DynamicsChromatin Remodeling and Cancer

Cited by 17

New pharmacological strategies for augmenting extinction learning in anxiety disorders

Sartori, S. B., & Singewald, N. (2017) · e-Neuroforum

Memory and Neural MechanismsPosttraumatic Stress Disorder Research

Cited by 3